Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Publication year range
1.
J Med Life ; 2(4): 414-25, 2009.
Article in English | MEDLINE | ID: mdl-20108756

ABSTRACT

BACKGROUND: Rheumatoid arthritis (RA) is associated with loss of overall functionality of the locomotion system and it is connected with substantial economic losses. OBJECTIVE: To describe the clinical characteristics and healthcare resource utilization characteristics and to analyze the correlations in a cross-sectional sample of 206 patients in Romania. METHOD: RA cases have been enrolled from southern and western part of the country, covering a surface of 23 counties. RESULTS: Particularly in the literature data, Romanian RA patients become work disabled at 5.65 +/- 5.99 years old after the diagnosis. At cohort level, retirement in the first year after RA diagnosis is of 22.9%. From those, 13% were treated with biologic DMARDs; those on non-biologic DMARDs were 28.6%. In oral therapy group the most prescribed drug is lefunomide (61.2%). RA has an important impact on pain, function and utility, influenced by social factors. Patients' follow up is often based on hospitalization. CONCLUSION: Currently, when the clinician may choose for one certain therapy or another, the social influence is still overwhelming at all the evaluation levels in RA patients, as well as at economic impact.


Subject(s)
Arthritis, Rheumatoid/diagnostic imaging , Adalimumab , Adolescent , Adult , Age Distribution , Aged , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Antibodies, Monoclonal/therapeutic use , Antibodies, Monoclonal, Humanized , Antirheumatic Agents/therapeutic use , Arthritis, Rheumatoid/complications , Arthritis, Rheumatoid/drug therapy , Disabled Persons , Etanercept , Female , Humans , Immunoglobulin G/therapeutic use , Infliximab , Male , Middle Aged , Radiography , Receptors, Tumor Necrosis Factor/therapeutic use , Romania/epidemiology , Severity of Illness Index , Young Adult
2.
Pneumologia ; 55(3): 128-9, 2006.
Article in Romanian | MEDLINE | ID: mdl-17144483

ABSTRACT

Recovery in COPD includes, as a mandatory stage, the patient's nutritional evaluation, followed by the necessary therapeutic indications. Weight loss has negative effects on the skeletal muscle mass, therefore a kinetic program, without being supported by the appropriate therapy, has a much lower effect. Recent studies show a beneficial effect generated by a high intake of vitamin C, vitamin E, omega-3 fat acid and nutritional supplements. The hormonal therapy is given a controversial place, but it requires extensive studies.


Subject(s)
Pulmonary Disease, Chronic Obstructive/diet therapy , Pulmonary Disease, Chronic Obstructive/rehabilitation , Dietary Fats, Unsaturated/administration & dosage , Fatty Acids, Omega-3/administration & dosage , Humans , Minerals/administration & dosage , Nutritional Support , Practice Guidelines as Topic , Quality of Life , Vitamins/administration & dosage
SELECTION OF CITATIONS
SEARCH DETAIL
...